Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pfe crawled date : 2022 - 12 - 22 save search
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis Everest Medicines announced that its licensing partner, Pfizer In...
Published: 2022-12-22 (Crawled : 12:00) - biospace.com/
CYDY | $0.1509 0.06% 810K
|
Manufacturing
|
| O: -4.34%
H: 0.35%
C: -5.13%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.48%
H: 0.56%
C: 0.45%
fda ema ulcerative colitis
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis Everest Medicines announced that its licensing partner, Pfizer Inc. has received acceptance from the U.S. Food and Drug Administration for review a New Drug Application for etrasimod for individuals living with moderately-to-severely active ulcerative colitis.
Published: 2022-12-22 (Crawled : 07:00) - biospace.com/
CYDY | $0.1509 0.06% 810K
|
Manufacturing
|
| O: -4.34%
H: 0.35%
C: -5.13%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.48%
H: 0.56%
C: 0.45%
fda drug active ema application review food living ulcerative colitis
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
Published: 2022-12-22 (Crawled : 01:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.48%
H: 0.56%
C: 0.45%
fda ema ulcerative colitis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.